Wholesale of pharmaceutical and medical goods
BLOSTRUPMOEN NORGE AS
Revenue 2024
NOK 33.7m
Operating profit
NOK 2.7m
Equity
NOK 866,000
Incorporated
2016
Employees
25
Share capital
NOK 30,000
Key figures · 2024
Current ratio
0.61
Equity ratio
4.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 8.1% | |
| Net margin (%%) | 6.1% | |
| Return on assets (%%) | 14.3% | |
| Likviditet | ||
| Current ratio | 0.61 | |
| Working capital | −6.9m | |
| Soliditet | ||
| Equity ratio (%%) | 4.5% | |
| Debt-to-equity ratio | 21.00 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.